-
Esophageal Cancer Awareness Month: 2022 Immunotherapy Research Updates
This April for Esophageal Cancer Awareness Month, discover the new research, new treatments, and progress for a…
-
FDA Immunotherapy Approvals in 2022
As drug development in cancer immunotherapy has accelerated, the U.S. Food and Drug Administration has made several…
-
Kidney Cancer Awareness Month: 2022 Immunotherapy Research Updates
This March for Kidney Cancer Awareness Month, discover the patient perspectives, clinical trials, and progress for a…
-
Colorectal Cancer Awareness Month: 2022 Immunotherapy Research Updates
This March for Colorectal Cancer Awareness Month, discover the latest clinical trials, research insights, and progress for…
-
Multiple Myeloma Awareness Month: 2022 Immunotherapy Research Updates
This March for Multiple Myeloma Awareness Month, discover the latest treatments, research insights, and progress for a…
-
Crossing the Country to Cure Cancer
Jarad Schofer became intrigued by the idea of walking across America and decided to raise money for…
-
CRI Highlights First Recipients of Postdoctoral Fellowship to Promote Racial Diversity in Immuno-Oncology
Meet three promising young scientists changing the face of immuno-oncology: Ryan K. Alexander, PhD, of Boston Children’s…
-
Cervical Cancer Awareness Month: 2022 Immunotherapy Research Updates
New research, new treatments, and how we’re working toward a future immune to cervical cancer
-
Dr. Dmitriy Zamarin Answers Questions About Ovarian Cancer and Immunotherapy after the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Dmitriy Zamarin, of Memorial Sloan Kettering Cancer Center, answers questions about immunotherapy clinical trials from the…
